RENALYTIX PLC - AMERICAN DEPOSITARY SHARES

Commencement of trading on OTCQB in the United States

08 10 2024 06:00:00 提供 Nasdaq GlobeNewswire

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

11 7 2024 06:00:03 提供 Nasdaq GlobeNewswire

Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination

27 6 2024 17:30:18 提供 Nasdaq GlobeNewswire

Medicare Issues Final Coverage Determination for kidneyintelX.dkd

14 6 2024 06:00:11 提供 Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

15 5 2024 06:00:14 提供 Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15

09 5 2024 06:00:12 提供 Nasdaq GlobeNewswire

Renalytix Announces Financing with Expected Size of up to $4 Million

08 4 2024 06:00:23 提供 Nasdaq GlobeNewswire

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

14 3 2024 06:00:45 提供 Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024

15 2 2024 06:00:32 提供 Nasdaq GlobeNewswire

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

09 2 2024 08:00:49 提供 Nasdaq GlobeNewswire

New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease

10 1 2024 06:00:50 提供 Nasdaq GlobeNewswire

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

14 11 2023 06:00:24 提供 Nasdaq GlobeNewswire

Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14

07 11 2023 06:00:59 提供 Nasdaq GlobeNewswire

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

06 10 2023 06:00:19 提供 Nasdaq GlobeNewswire

Renalytix Reports Full Year Fiscal 2023 Results

28 9 2023 06:00:50 提供 Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28

25 9 2023 06:00:40 提供 Nasdaq GlobeNewswire

Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer

07 9 2023 06:00:27 提供 Nasdaq GlobeNewswire

Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

03 8 2023 06:00:29 提供 Nasdaq GlobeNewswire

Renalytix Announces Middle East Distribution Agreement with Vector Pharma

21 7 2023 06:00:08 提供 Nasdaq GlobeNewswire

Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions

07 7 2023 06:00:47 提供 Nasdaq GlobeNewswire